Manja Meggendorfer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 21

Top Topics

Acute Myeloid Leukemia

Peripheral Blood

Top Venues

Nature communications

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia 38 (7) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann, Christian Pohlkamp, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Genomic landscape of CCUS compared to MDS and its implications on risk prediction. Leukemia (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia (2024)
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter, Christian Pohlkamp, Isolde Summerer, Henning Ruge, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients. Leukemia 38 (7) (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, Juraj Bodo, Bartlomiej P Przychodzen, Hussein Awada, Nakisha Williams, Carmelo Gurnari, Naomi Kawashima, Mai Aly, Arda Durmaz, Minako Mori, Ben Ponvilawan, Tariq Kewan, Waled Bahaj, Manja Meggendorfer, Babal Kant Jha, Valeria Visconte, Heesun Joyce Rogers, Torsten Haferlach, Jaroslaw P Maciejewski
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting. Nature communications 15 (1) (2024)
Holly Lee, Sungwoo Ahn, Ranjan Maity, Noemie Leblay, Bachisio Ziccheddu, Marietta Truger, Monika Chojnacka, Anthony Cirrincione, Michael A Durante, Remi Tilmont, Elie Barakat, Mansour Poorebrahim, Sarthak Sinha, John McIntyre, Angela M Y Chan, Holly Wilson, Shari Kyman, Amrita Krishnan, Carl Ola Landgren, Wencke Walter, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach, Hermann Einsele, Klaus Martin Kortüm, Stefan Knop, Jean Baptiste Alberge, Andreas Rosenwald, Jonathan J Keats, Leo Rasche, Francesco Maura, Paola Neri, Nizar J Bahlis
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nature medicine (2023)
Elizabeth Heyes, Anna S Wilhelmson, Anne Wenzel, Gabriele Manhart, Thomas Eder, Mikkel B Schuster, Edwin Rzepa, Sachin Pundhir, Teresa D'Altri, Anne-Katrine Frank, Coline Gentil, Jakob Woessmann, Erwin M Schoof, Manja Meggendorfer, Juerg Schwaller, Torsten Haferlach, Florian Grebien, Bo Torben Porse
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression. Nature communications 14 (1) (2023)
Sandra Huber, Torsten Haferlach, Heiko Müller, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Constance Baer, Wolfgang Kern, Claudia Haferlach
MDS subclassification-do we still have to count blasts? Leukemia (2023)
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC. Leukemia (2023)
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann
AML classification in the year 2023: How to avoid a Babylonian confusion of languages. Leukemia (2023)
Maki Sakuma, Piers Blombery, Manja Meggendorfer, Claudia Haferlach, Markus Lindauer, Uwe M Martens, Wolfgang Kern, Torsten Haferlach, Wencke Walter
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies. Leukemia (2023)
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann, Isolde Summerer, Irene Fuhrmann, Constance Baer, Wolfgang Kern, Claudia Haferlach
Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts. Leukemia (2022)